Free Alerts   Login
Health Care › Biological Products (No Diagnostic Substances)

SRRK Stock Price Correlated With Scholar Rock Holding Financials

SRRK Stock Price vs. Quarterly
SRRK
Income Statement
Cash Flow
Balance Sheet

SRRK Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

SRRK Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

SRRK Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Samsara BioCapital GP, LLC   10% Owner
2,189,781 sh at $7
$15,000,000
Buy
AKKARAJU SRINIVAS   Director and 10% Owner
2,189,781 sh at $7
$15,000,000
Buy
Invus Public Equities, L.P.   10% Owner
2,199,931 sh at $7
$15,086,736
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Artal Group S.A.
9,059,507 sh
 
$64,322
FMR
8,005,654 sh
291,156 sh
4%
$56,840
-$1,326
Price T Rowe Associates /Md/
7,171,952 sh
86,849 sh
1%
$50
-$3
Redmile Group
4,733,248 sh
329,408 sh
7%
$33,606
$401
Blackrock.
3,480,645 sh
689,674 sh
25%
$24,713
$3,669
Vanguard Group
2,052,718 sh
67,959 sh
3%
$14,574
-$390
Orbimed Advisors
2,033,789 sh
1,298,144 sh
176%
$14,440
$8,893
Goldman Sachs Group
1,088,074 sh
-302,731 sh
-22%
$7,725
-$2,762
Geode Capital Management
853,072 sh
184,218 sh
28%
$6,057
$1,014
State Street
813,984 sh
39,204 sh
5%
$5,779
-$63
Laurion Capital Management Lp
553,700 sh
15,902 sh
3%
$3,931
-$124
AXA
539,762 sh
48,004 sh
10%
$3,832
$124
Northernrp
409,433 sh
95,676 sh
30%
$2,906
$540
Td Asset Management
336,294 sh
91,371 sh
37%
$2,388
$541
Sectoral Asset Management
310,398 sh
64,663 sh
26%
$2,204
$351
Vontobel Holding.
310,398 sh
64,663 sh
26%
$2,204
$351
Charles Schwab Investment Management
302,384 sh
48,382 sh
19%
$2,147
$232
Dimensional Fund Advisors
291,842 sh
93,235 sh
47%
$2,073
$578
Morgan Stanley
220,556 sh
-26,899 sh
-11%
$1,566
-$300
Ubs Oconnor
212,581 sh
10,000 sh
5%
$1,509
-$18

Free historical financial statements for Scholar Rock Holding Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 19 quarters since 2019. Compare with SRRK stock chart to see long term trends.

Data imported from Scholar Rock Holding Corp SEC filings. Check original filings before making any investment decision.